Press Releases

GlobeNewswire, Inc.

Registrational RESET-Myositis® clinical data on track to be reported in mid-2027 to support 2H27 BLA submission for rese-cel Juvenile myositis Phase 1/2 data expected to be submitted with BLA to support potential FDA Priority Review Voucher...

GlobeNewswire, Inc.

LOS ANGELES, Aug. 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that the Puppy Blend from Holistic Vet Blend, a nutrient premix supplement created by both a veterinarian and an animal nutritionist to balance homemade...

GlobeNewswire, Inc.

Updated data from the MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track to be reported in Fall 2026; update to include detailed analyses of patients treated at or below a dose cap Updated data from the MICVO Phase 1/2 combination study...

GlobeNewswire, Inc.

Key Highlights Record Q2 revenue of approximately $4.5 million, representing another all-time high for the Company.

GlobeNewswire, Inc.

First-ever oral direct KCC2 activator, OV4071, advancing in an ongoing Phase 1 study Initiated Phase 2 proof-of-concept and photosensitivity studies for OV329, a next-generation GABA-AT inhibitor A newly-formed portfolio company with funds advised...

GlobeNewswire, Inc.

FORT LAUDERDALE, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery...

GlobeNewswire, Inc.

Planning to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene) in localized, intermediate- to high-risk prostate cancer in Q4 2026 Pivotal phase 3 clinical data published in The Lancet Oncology demonstrated a...

GlobeNewswire, Inc.

Recent capital raise and warrant exercises extend cash runway through second quarter of 2027 Conference call begins at 9:00 a.m. Eastern time today MINNEAPOLIS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology...

GlobeNewswire, Inc.

First patients treated in randomized Phase 2 trial C-1300-02 were alive at Day 28, with improved oxygenation, resolution of ARDS with return to spontaneous breathing and liberation from vasopressor support Clinical recovery and biologic readouts...

GlobeNewswire, Inc.

- Obexelimab BLA submission for the treatment of IgG4-RD accepted by FDA; PDUFA target action date of May 27, 2027 - - New study data confirm bioequivalence of obexelimab single-dose prefilled autoinjector pen compared to prefilled syringes - -...

GlobeNewswire, Inc.

Advanced zolucatetide across multiple Wnt/β-catenin-driven diseases, including progress toward planned Phase 3 registrational trial in desmoid tumors Announced strategic research collaboration with Regeneron to develop Antibody-Helicon Conjugates,...

GlobeNewswire, Inc.

SYMON-II pivotal clinical study completes targeted enrollment of 750 patients Company advances toward planned 510(k) submission and commercialization with US manufacturing contract signed to mitigate supply-chain risk Company ends second quarter...

EIN Presswire

Chery UK returns to CarFest for a second year, once again as sponsor of KidsFest, the festival’s dedicated family zone LONDON, UNITED KINGDOM, August 13, 2026 /⁨EINPresswire.com⁩/ -- Chery UK will return to CarFest this summer, building on a...

EIN Presswire

New report from Socha Branding connects farm economics, consumer health, CPG growth and new science to show market shifts DENVER, CO, UNITED STATES, August 12, 2026 /⁨EINPresswire.com⁩/ -- The U.S. food market is changing what it rewards.

GlobeNewswire, Inc.

U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) with Priority Review for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); Prescription Drug User Fee Act (PDUFA) target action date of February 12,...

GlobeNewswire, Inc.

Austin, TX, USA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Whey Protein Market Size, Trends and Insights By Type (Whey Protein Isolates (WPI), Whey Protein Concentrates (WPC), Whey Protein...

GlobeNewswire, Inc.

Total product sales of €64.0 million In-line with expectations; full-year guidance of €135 -150 million reaffirmed Solid cash position of €121.5 million as of end June 2026 Reflects disciplined cash management and proceeds from the recent reserved...

EIN Presswire

HNL Lab Medicine employees donate school supplies and food to benefit South Mountain Middle School students and families.

GlobeNewswire, Inc.

– Completed enrollment in Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD – – Expect to report topline results from both Phase 2 Seabreeze STAT studies in September 2026 – – Cash runway expected for a period of at least...

GlobeNewswire, Inc.

FORT LAUDERDALE, Fla., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (the "Company") today announced its intention to change its corporate name to Endovia Health Sciences, Inc., effective August 21, 2026. At...